Agilus Diagnostics Revolutionizes Genomic Testing with 3-Day Turnaround for Myeloid Malignancies
Agilus Diagnostics, India's largest diagnostic network, has set a new industry standard with its breakthrough genomic testing services, offering a 3-day turnaround time (TAT) for myeloid malignancies. This achievement addresses a major challenge in cancer care, ensuring faster diagnoses and timely treatment.
The genomic testing market in India, valued at $150 million, is growing at over 15% annually, driven by advancements in personalized medicine. Genomic testing is transforming cancer diagnostics by providing detailed insights into genetic mutations, enabling clinicians to tailor treatments with higher precision. By delivering early detection and personalized care, this technology marks a significant shift in cancer management. Agilus Diagnostics is well-positioned to lead this transformation with its rapid, precise, and comprehensive solutions.
With NGS power, Agilus Myeloid Genomics Testing screens for all alterations in 79 genes by checking for significant mutations and fusions. These personalized treatment approaches address the challenge of AML, MPN, and similar disorders. Results include the expertise of expert molecular pathologists through a recognized system for worldwide risk assessments as well as therapies personalized for an individual patient.
Agilus also has Genomic Profiling Precision Assay, analyzing 50 critical genes for lung, colon, and breast cancer, among others. Results will be returned within two days if using liquid biopsy and seven days with tissue block. This can quickly facilitate the best clinical decisions possible for a better patient outcome.
Time is of the essence in precision oncology. Our 3-day TAT for myeloid malignancies is a game-changer, significantly reducing delays in diagnoses and treatment," said Dr. Anand K, Managing Director & CEO of Agilus Diagnostics. Other labs take 2-3 weeks, and this faster process at Agilus Diagnostics improves patient care, reduces hospital visits, and overall experience.
Agilus focuses on speed, precision, and patient-centricity, making it a global leader in personalized medicine. Advanced technology and individualized reporting by Agilus mean actionable insights for clinicians, cementing its position as a leading player in precision diagnostics and driving its mission of delivering world-class healthcare to India.
